☆ 4.3 Article

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

STRAHLENTHERAPIE UND ONKOLOGIE (2020)

期刊

STRAHLENTHERAPIE UND ONKOLOGIE

卷 196, 期 5, 页码 417-420

出版社

SPRINGER HEIDELBERG

DOI: 10.1007/s00066-020-01603-1

关键词

Radiosurgery; Stereotactic Body Radiotherapy; SRS; SBRT; Definition

类别

Oncology Radiology, Nuclear Medicine & Medical Imaging

资金

Projekt DEAL

向作者/读者索取更多资源

Protocol

Reagent

摘要

Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death

Chang W. Song, Eli Glatstein, Lawrence B. Marks, Bahman Emami, Jimm Grimm, Paul W. Sperduto, Mi-Sook Kim, Susanta Hui, Kathryn E. Dusenbery, L. Chinsoo Cho

Summary: High-dose irradiation in SBRT and SRS induces tumor cell death through vascular damage and increased antitumor immunity, in addition to direct tumor cell killing. Additional research is needed to further investigate the mechanisms of normal tissue damage caused by high-dose irradiation.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Oncology

Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM

A. J. Conde-Moreno, D. Zucca Aparicio, M. J. Perez-Calatayud, F. Lopez-Campos, F. Celada Alvarez, C. Rubio Rodriguez, P. Fernandez-Leton, A. Gomez-Caamano, J. Contreras Martinez

Summary: Patient management now requires a multidisciplinary approach due to the increasing complexity of Medicine, leading to more specialized clinical practice. The Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics collaborated to establish roles and responsibilities for healthcare professionals in performing SRS and SBRT treatments, in response to recent changes in Spanish Legislation governing radiotherapy and radiological protection. This effort aims to clearly define the responsibilities of each professional group and outline their competencies in the radiotherapy process.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option?

Alba Fiorentino, Fabiana Gregucci, Ilaria Bonaparte, Nicola Vitulano, Alessia Surgo, Rosario Mazzola, Antonio Di Monaco, Roberta Carbonara, Filippo Alongi, Tommaso Langialonga, Massimo Grimaldi

Summary: SABR has been used for the treatment of cardiac arrhythmias based on preclinical and clinical data, demonstrating it as a safe and effective noninvasive treatment approach with a good response time of 2-3 months. The treatment dose is crucial for efficacy, and clinical data support the feasibility, effectiveness, and safety of SABR for refractory ventricular arrhythmias.

RADIOLOGIA MEDICA (2021)

添加到收藏夹

Article Oncology

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases

Paolo Sogono, Mathias Bressel, Steven David, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Nicholas Hardcastle, Tomas Kron, Greg Wheeler, Gerard G. Hanna, Michael MacManus, David Ball, Shankar Siva

Summary: The study showed that single-fraction stereotactic body radiation therapy is safe and effective for patients with oligometastatic disease, reducing the number of attendances and improving efficiency. Patients had high overall survival rates and a significant proportion remained treatment-free for several years after therapy.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration

Petr Burkon, Jan Trna, Marek Slavik, Radim Nemecek, Tomas Kazda, Petr Pospisil, Milan Dastych, Michal Eid, Ivo Novotny, Tomas Prochazka, Miroslav Vrzal

Summary: Pancreatic cancer is the third leading cause of cancer death in the developed world. Surgical resection is the only cure, but for advanced cases, neoadjuvant therapy and stereotactic body radiotherapy (SBRT) may improve treatment outcomes and offer convenience and tolerability.

BIOMEDICINES (2022)

添加到收藏夹

Article Oncology

Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials

D. Pezzulla, G. Macchia, S. Cilla, M. Buwenge, M. Ferro, P. Bonome, C. Romano, A. Zamagni, V. Valentini, A. G. Morganti, F. Deodato

Summary: Fractionated stereotactic body radiotherapy shows significant efficacy in controlling nodal metastases in prostate cancer, with notable impact on late toxicity and survival rates.

CLINICAL & EXPERIMENTAL METASTASIS (2021)

添加到收藏夹

Article Oncology

Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study

Luca Nicosia, Piera Navarria, Valentina Pinzi, Martina Giraffa, Ivana Russo, Paolo Tini, Niccolo Giaj-Levra, Filippo Alongi, Giuseppe Minniti

Summary: This study evaluated the efficacy and toxicity of linear accelerator-based stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in patients with brainstem metastases. The results showed that this treatment approach provided excellent local control with low toxicity and no detrimental effects on overall survival. Concurrent targeted therapy may be associated with longer survival.

RADIATION ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus

Barbara A. Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, Simone Giovanni Gugliandolo, Dario Zerini, Federica Corso, Sara Gandini, Filippo Alongi, Alberto Bossi, Philip Cornford, Berardino De Bari, Valerie Fonteyne, Peter Hoskin, Bradley R. Pieters, Alison C. Tree, Stefano Arcangeli, Donald B. Fuller, Ciro Franzese, Jean-Michel Hannoun-Levi, Guillaume Janoray, Linda Kerkmeijer, Young Kwok, Lorenzo Livi, Mauro Loi, Raymond Miralbell, David Pasquier, Michael Pinkawa, Nathaliel Scher, Marta Scorsetti, Mohamed Shelan, Alain Toledano, Nicholas van As, Andrea Vavassori, Thomas Zilli, Matteo Pepa, Piet Ost

Summary: This study investigated expert opinions on salvage SBRT for intraprostatic relapse after RT. Through three rounds of Delphi consensus, experts reached a certain level of consensus on selection criteria, diagnostic procedures, and therapeutic approaches.

CANCER TREATMENT REVIEWS (2021)

添加到收藏夹

Article Oncology

Stereotactic management of arrhythmia- radiosurgery in treatment of ventricular tachycardia (SMART-VT). Results of a prospective safety trial

Marcin Miszczyk, Mateusz Sajdok, Jacek Bednarek, Tomasz Latusek, Wojciech Wojakowski, Bartlomiej Tomasik, Krystian Wita, Tomasz Jadczyk, Radoslaw Kurzelowski, Anna Drzewiecka, Magdalena Cybulska, Rafal Gardas, Grzegorz Jarosinski, Lukasz Dolla, Aleksandra Grzadziel, Kamil Zub, Adam Bekman, Konrad Kaminiow, Anna Kozub, Krzysztof S. Golba, Slawomir Blamek

Summary: This study evaluated the safety and efficacy of stereo-tactic arrhythmia radioablation (STAR) in patients with ventricular tachycardia (VT). The results showed that STAR is a safe and effective treatment, reducing VT burden. However, long-term outcomes still need to be evaluated.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases

Matthias Guckenberger, Frederick Mantel, Reinhart A. Sweeney, Maria Hawkins, Jose Belderbos, Merina Ahmed, Nicolaus Andratschke, Indira Madani, Michael Flentje

Summary: The study demonstrates that fractionated SBRT is effective in providing long-term pain relief and improved survival rates for patients with painful spinal metastases. Partial pain response was achieved in some patients at 3 months' follow-up and remained stable up to 5 years. Furthermore, fractionated SBRT resulted in long-term improvements in multiple dimensions of the EuroQol 5-Dimension Questionnaire.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Health Care Sciences & Services

Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers

Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Margherita Rotondi, Riccardo Carlo Sigillo, Maurizio Valeriani, Mattia Falchetto Osti

Summary: This study retrospectively analyzed the clinical outcomes of stereotactic body radiation therapy (SBRT) for lymph node metastases from gynecological cancers. The results showed that SBRT achieved excellent tumor control with low toxicities.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

Article Oncology

A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)

Luca Nicosia, Elena Rossato, Renato Avesani, Fabio Marchioretto, Giuseppe Armani, Massimo Zamperini, Giovanni Foti, Fatemeh Jafari, Antonio De Simone, Ruggero Ruggieri, Filippo Alongi, Federico Ferrari

Summary: Spasticity is a clinical condition caused by central nervous system damage, affecting patients' mobility and quality of life. Stereotactic radiosurgery (SRS) may serve as a non-invasive treatment option. This paper presents the preliminary results of the first clinical use of this novel technique.

RADIOTHERAPY AND ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice

Emma M. Dunne, Simon S. Lo, Mitchell C. Liu, Alanah Bergman, Robert Kosztyla, Eric L. Chang, Ung-Kyu Chang, Samuel T. Chao, Nicolas Dea, Salman Faruqi, Amol J. Ghia, Kristin J. Redmond, Scott G. Soltys, Arjun Sahgal

Summary: This study highlights the lack of uniformity in thecal sac delineation among high-volume practitioners and proposes contouring recommendations for consistent and safe practice. The study suggests guidelines for contouring the thecal sac to encompass all intrathecal spinal nerve roots and the bony canal as a surrogate for extra thecal nerves roots. Further modifications may be needed based on dosimetric data and failure analyses of clinical data sets.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

添加到收藏夹

Article Oncology

SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain

M. J. Perez-Calatayud, A. J. Conde-Moreno, F. J. Celada-alvarez, C. Rubio, F. Lopez-Campos, A. Navarro-Martin, L. Arribas, M. Santos, J. Lopez-Torrecilla, J. Perez-Calatayud

Summary: The study surveyed radiation oncology departments in Spain to assess prescription methods and dose heterogeneity in SBRT and SRS treatment. The results revealed significant inter-centre variability in prescription criteria, which could potentially impact treatment outcomes. This information will be used to develop recommendations for dose prescription and heterogeneity in SRS/SBRT by the SEOR SBRT-SG.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Arteriovenous Malformation

Leila Maria Da Roz, Geovanne Pedro Mauro, Vinicius de Carvalho Gico, Eduardo Weltman, Evandro Cesar de Souza, Eberval Gadelha Figueiredo, Manoel Jacobsen Teixeira

Summary: This study retrospectively reviewed AVM patients treated with radiation or a combination of radiation and embolization. The results showed that stereotactic radiosurgery plays an important role in AVM treatment and should be preferred whenever possible.

WORLD NEUROSURGERY (2023)

添加到收藏夹

Article Oncology

An ESTRO-ACROP guideline on quality assurance and medical physics commissioning of online MRI guided radiotherapy systems based on a consensus expert opinion

Stephanie Tanadini-Lang, Geoff Budgell, Omar Bohoudi, Stefanie Corradini, Davide Cusumano, Gorkem Gungor, Linda G. W. Kerkmeijer, Faisal Mahmood, Simeon Nill, Miguel A. Palacios, Michael Reiner, Daniela Thorwarth, Lotte Wilke, Jochem Wolthaus

Summary: The objective of this study was to define QA tests for oMRgRT systems and to identify important medical physics aspects for installation and commissioning. Twenty-four potentially important QA tests were identified, along with eleven tasks and aspects related to construction, workflow development, and training. A program for QA and commissioning of oMRgRT systems was developed to support safe handling of such systems.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study

Josef A. Buchner, Florian Kofler, Lucas Etzel, Michael Mayinger, Sebastian M. Christ, Thomas B. Brunner, Andrea Wittig, Bjoern Menze, Claus Zimmer, Bernhard Meyer, Matthias Guckenberger, Nicolaus Andratschke, Rami A. El Shafie, Juergen Debus, Susanne Rogers, Oliver Riesterer, Katrin Schulze, Horst J. Feldmann, Oliver Blanck, Constantinos Zamboglou, Konstantinos Ferentinos, Robert Wolff, Kerstin A. Eitz, Stephanie E. Combs, Denise Bernhardt, Benedikt Wiestler, Jan C. Peeken

Summary: This study aimed to develop and validate a neural network for automatic GTV segmentation in brain metastases. A 3D-U-Net model was trained and tested on a cohort of patients from different centers, achieving reliable and accurate segmentation results.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Quality assurance process within the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial for the fusion of electroanatomical mapping and radiotherapy planning imaging data in cardiac radioablation

Michael Mayinger, Judit Boda-Heggemann, Felix Mehrhof, David Krug, Stephan Hohmann, Jingyang Xie, Stefanie Ehrbar, Boldizsar Kovacs, Roland Merten, Melanie Grehn, Adrian Zaman, Jens Fleckenstein, Lena Kaestner, Daniel Buergy, Boris Rudic, Anne Kluge, Leif-Hendrik Boldt, Jurgen Dunst, Hendrik Bonnemeier, Ardan M. Saguner, Nicolaus Andratschke, Oliver Blanck, Achim Schweikard

Summary: A novel quality assurance process for EAM-to-RTPI target transport was developed and evaluated within the multi-center multi-platform framework of the RAVENTA trial. The CARDIO-RT software enabled platform independent registration and automated segmentation of LV-RTC. Structural analyses revealed substantial differences between manual target transfer and target transport using CARDIO-RT in five clinical cases.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis

Constantin Dreher, Gustavo R. R. Sarria, Georgia Miebach, Christel Weiss, Daniel Buergy, Paulina Wojtal, Anoshirwan A. A. Tavakoli, David Krug, Hans Oppitz, Frank A. A. Giordano, Marcus Both, Frank Lohr, Juergen Dunst, Oliver Blanck, Judit Boda-Heggemann

Summary: This retrospective analysis included 57 patients with liver metastases who underwent gantry-based or robotic-based SBRT treatment and had long-term follow-up. It was found that morphological changes in the liver decreased significantly in the short-term, and an increased mean liver dose was associated with larger morphological changes.

ACTA ONCOLOGICA (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe

Melanie Grehn, Stefano Mandija, Marcin Miszczyk, David Krug, Bartlomiej Tomasik, Kristine E. Stickney, Pino Alcantara, Filippo Alongi, Matteo Anselmino, Ricardo Salgado Aranda, Brian Balgobind, Judit Boda-Heggemann, Leif-Hendrik Boldt, Nicola Bottoni, Jakub Cvek, Olgun Elicin, Gaetano Maria De Ferrari, Rutger J. Hassink, Colien Hazelaar, Gerhard Hindricks, Coen Hurkmans, Cinzia Iotti, Tomasz Jadczyk, Otakar Jiravsky, Raphaël Jumeau, Steen Buus Kristiansen, Mario Levis, Manuel Algara Lopez, Julio Marti-Almor, Felix Mehrhof, Ditte Sloth Moller, Giulio Molon, Alexandre Ouss, Petr Peichl, Jiri Plasek, Pieter G. Postema, Aurelio Quesada, Tobias Reichlin, Roberto Rordorf, Boris Rudic, Ardan M. Saguner, Rachel M. A. ter Bekke, Jose Lopez Torrecilla, Esther G. C. Troost, Viviana Vitolo, Nicolaus Andratschke, Katja Zeppenfeld, Slawomir Blamek, Martin Fast, Ludovica de Panfilis, Oliver Blanck, Etienne Pruvot, Joost J. C. Verhoeff

Summary: The STOPSTORM consortium, funded by the EU Horizon 2020 Framework, aims to establish a standardized treatment and outcome platform for investigating STAR in ventricular tachycardia. The consortium consists of 31 clinical and research institutions and is divided into nine work packages. A comprehensive questionnaire was conducted to review the current clinical practice of STAR in Europe, highlighting potential areas of optimization and harmonization.

EUROPACE (2023)

添加到收藏夹

Article Oncology

Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sezary Syndrome

Khaled Elsayad, Carsten Weishaupt, Christos Moustakis, Moritz Fabian Danzer, Elisa Christina Mueller, Daniel Rolf, Rene Stranzenbach, Elisabeth Livingstone, Nina Booken, Rudolf Stadler, Hans Theodor Eich

Summary: The study assessed the safety and efficacy of ultrahypofractionated low-dose total skin electron beam therapy (TSEBT) in patients with advanced mycosis fungoides (MF) or Sezary syndrome (SS). The results showed that TSEBT achieved good disease control and symptom palliation with acceptable toxicity.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

A retrospective multi-center feasibility study of a new PTV margin estimation approach for moving targets using CyberKnife log files

Payam Samadi Miandoab, Shahyar Saramad, Saeed Setayeshi, Oliver Blanck

Summary: This study investigates a new approach for estimating PTV margin for moving tumors treated with robotic SBRT. The study found that using the modified Van Herk formula can provide more precise target localization and suggest using adaptive PTV margins in future fractions to improve clinical outcomes.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2023)

添加到收藏夹

Article Oncology

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities

E. Gkika, D. Kostyszyn, T. Fechter, C. Moustakis, F. Ernst, J. Boda-Heggemann, G. Sarria, K. Dieckmann, S. Dobiasch, M. N. Duma, F. Eberle, K. Kroeger, B. Haeussler, V. Izaguirre, D. Jazmati, S. Lautenschlaeger, F. Lohaus, F. Mantel, J. Menzel, S. Pachmann, M. Pavic, K. Radlanski, O. Riesterer, S. Gerum, F. Roeder, J. Willner, S. Barczyk, D. Imhoff, O. Blanck, A. Wittig, M. Guckenberger, Anca-L. Grosu, T. B. Brunner

Summary: The purpose of this study was to evaluate interobserver agreement on target volume definition for pancreatic cancer within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes. The results showed that PET/CT and 4D PET/CT had the best agreement for defining treatment volumes in pancreatic SBRT. Overall, this study can contribute to improving the effectiveness of pancreatic SBRT.

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

添加到收藏夹

Article Biology

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases

Leonie Johannwerner, Elisa M. Werner, Oliver Blanck, Stefan Janssen, Florian Cremers, Nathan Y. Yu, Dirk Rades

Summary: Based on the study, a maximum biologically effective dose (BED) of 45 Gy(12) is recommended for stereotactic radiosurgery (SRS) of brain metastases measuring 21-30 mm. However, for de novo lesions without prior brain irradiation, the tolerable BED may be higher than 45 Gy(12). This study investigated the occurrence of radiation necrosis (RN) after single-fraction SRS or fractionated stereotactic radiotherapy (FSRT) with a BED greater than 49 Gy(12) for radiotherapy-naive brain metastases. The results showed that FSRT with BED > 49 Gy(12) had a lower risk of RN for metastases larger than 20 mm and appeared to be safer than SRS for such lesions.

BIOLOGY-BASEL (2023)

添加到收藏夹

Article Oncology

Identifying core MRI sequences for reliable automatic brain metastasis segmentation

Josef A. Buchner, Jan C. Peeken, Lucas Etzel, Ivan Ezhov, Michael Mayinger, Sebastian M. Christ, Thomas B. Brunner, Andrea Wittig, Bjoern H. Menze, Claus Zimmer, Bernhard Meyer, Matthias Guckenberger, Nicolaus Andratschke, Rami A. El Shafie, Juergen Debus, Susanne Rogers, Oliver Riesterer, Katrin Schulze, Horst J. Feldmann, Oliver Blanck, Constantinos Zamboglou, Konstantinos Ferentinos, Angelika Bilger, Anca Grosu, Robert Wolff, Jan S. Kirschke, Kerstin Eitz, Stephanie Combs, Denise Bernhardt, Daniel Rueckert, Marie Piraud, Benedikt Wiestler, Florian Kofler

Summary: This study compares the performance of different MRI sequences in automated brain metastasis (BM) segmentation. The T1-CE sequence alone achieved the best segmentation performance for BM, while the combination of T1-CE and T2-FLAIR sequences was important for edema segmentation.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Review Oncology

Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients- A STOPSTORM.eu consortium review

Raoul R. F. Stevens, Colien Hazelaar, Martin F. Fast, Stefano Mandija, Melanie Grehn, Jakub Cvek, Lukas Knybel, Pavel Dvorak, Etienne Pruvot, Joost J. C. Verhoeff, Oliver Blanck, Wouter van Elmpt

Summary: This review examined the cardiorespiratory motion data in Stereotactic Arrhythmia Radioablation (STAR) and found limited detailed data on the subject. There were inconsistencies in reported parameters, making data comparison difficult. Due to the high patient-specific nature of cardiorespiratory motion, individual motion management strategies are highly recommended during imaging, planning, and treatment for STAR.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Electroanatomical mapping after cardiac radioablation for treatment of incessant electrical storm: a case report from the RAVENTA trial

Lena Kaestner, Judit Boda-Heggemann, Hannah Fanslau, Jingyang Xie, Achim Schweikard, Frank A. Giordano, Oliver Blanck, Boris Rudic

Summary: In this study, we presented a case of a patient with a poor prognosis after myocardial infarction, who had refractory ventricular tachycardia and could not be treated effectively with antiarrhythmic drugs, implantable cardioverter-defibrillator implantation, or repeated catheter ablation. The patient was introduced to the radiation oncology department for emergency stereotactic arrhythmia radioablation (STAR) as a bail-out therapy, and achieved a good outcome.

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

添加到收藏夹

Editorial Material Oncology

Treatment Decisions for hepatocellular Carcinoma: Findings from the TRENDY Study

Danny Jazmati, Judit Boda-Heggemann, Oliver Blanck, David Krug

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

添加到收藏夹

Article Oncology

Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium

Brian V. Balgobind, Jorrit Visser, Melanie Grehn, Marianne Marquard Knap, Dirk de Ruysscher, Mario Levis, Pino Alcantara, Judit Boda-Heggemann, Marcus Both, Salvatore Cozzi, Jakub Cvek, Edith M. T. Dieleman, Olgun Elicin, Niccolo Giaj-Levra, Raphael Jumeau, David Krugb, Manuel Algara Lopez, Michael Mayinger, Felix Mehrhof, Marcin Miszczyk, Maria Jose Perez-Calatayud, Luuk H. G. van der Pol, Peter-Paul van der Toorn, Viviana Vitolo, Pieter G. Postema, Etienne Pruvot, Joost C. Verhoefft, Oliver Blanck

Summary: This multi-centre benchmark study by STOPSTORM consortium showed high agreement in contouring standard radiotherapy OAR, but larger disagreements were observed in contouring cardiac substructures which may have significant impact on STAR treatment planning and dosimetry evaluation. Consensus guidelines for critical structure contouring in STAR were established to standardize OAR contouring.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function

Martijn H. van der Ree, Wiert F. Hoeksema, Adrian Luca, Jorrit Visser, Brian Balgobind, Michiel Zumbrink, Raymond Spier, Claudia Herrera-Siklody, Justin Lee, Matthew Bates, Jim Daniel, Clive Peedell, Judit Boda-Heggemann, Boris Rudic, Roland Merten, Edith M. Dieleman, Cristopher A. Rinaldi, Shahreen Ahmad, John Whitaker, Pranav Bhagirath, Matthew Q. Hatton, Stephen Riley, Melanie Grehn, Luis Schiappacasse, Oliver Blanck, Stephan Hohmann, Etienne Pruvot, Pieter G. Postema

Summary: This retrospective study evaluated the impact of STAR treatment on ICD functioning. The results showed that within the reported dose range, STAR treatment did not result in major ICD malfunction or clinically relevant alterations in ICD functioning. This indicates that STAR treatment is safe in terms of ICD functioning.

RADIOTHERAPY AND ONCOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.